Compliance Strategy for Small to Midsized Companies

February 22, 2013

 

Published for Pharmaceutical Compliance Monitor

On Feb. 20, 2013, Jim Hoover’s article, “Compliance Strategy for Small to Midsized Companies,” published in the online version of Pharmaceutical Compliance Monitor. In the article, Jim discusses the basic steps that small to mid-sized pharmaceutical companies should take when conducting an internal investigation. He instructs  companies to carefully consider the scope and limits of the investigation, who should conduct the investigation, how to protect the relevant privileges, and the possible outcomes of the investigation, prior to conducting the investigation. By fully considering these factors, Jim suggests that companies will be in a better position to correct any problems identified and determine whether or not self-disclosure is warranted. For the full article, please click here.  





Legal Disclaimer:
No representation is made that the quality of services to be performed is greater than the quality of legal services performed by other lawyers.

Featured Attorneys

send article

TESTIMONIALS

  • “He is great. The most important thing I think is judgment, whether more aggressive or more conservative than a firm’s first inclination. Tom’s got a great sense of discretion and judgment and he clearly knows the topic area very well. We never have an issue with us having to prompt ‘try this theory’. He’s smart and very pleasant, responsive as anything.”

    -Chambers 2012

  • "He's a very good attorney: diligent, thorough and always on top of things. A real trial lawyer."

    -Chambers 2013

  • “The coordination between each individual attorney appeared smooth. I was happy with the client service.”

    -Chambers 2012

  • "Rik Tozzi . . . adds further strength to this talented team and has been integral to the group's ongoing representation . . . in relation to a potential $200 million RICO class action."

    -Chambers 2012

  • "I am an employee of a large bank and responsible for a complex commercial real estate portfolio of problem loans and special assets.  I find Erich to be a most valuable resource and team member.  Erich is totally engaged in evaluating the bank's position related to the debt obligation(s), the collateral securing the debt and, when possible, offering alternative solutions that oftentimes lead to enhanced resolutions benefiting both the customer and the bank.  His proactive problem identification, problem prevention and problem solving skills make him my "go to" legal counsel."

    -Anonymous